- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
November 2nd, 2007
At least that's the hope, but others are not as sanguine. Jurvetson has been an especially visible booster of nanotechnology, the science of fabricating new products at the atomic and molecular levels. Among other things, he has spoken on panels, gone to Washington to lobby for research funds, and talked up the field's potential in the press. His company has also invested approximately $100 million in 30 nanotech-related companies. But so far, nanotech remains an area with potential only, with no hugely profitable nanotechnology firms having been started yet.
"To me, he has become Mr. Nanotech," says Lawrence Aragon, editor in chief of Venture Capital Journal, a trade publication, of Jurvetson. "If there's a big winner in there, he will be totally validated. But that's the trick with V.C. You can be right about a technology, and your timing could be completely wrong."
|Related News Press|
BESSTECH Announces $250K Investment from Eastern New York Angels : Funding will accelerate commercialization of BESSTECH’s innovative lithium-ion battery electrode technology and enable hiring of key personnel May 13th, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
This Slinky lookalike 'hyperlens' helps us see tiny objects: The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists' ability to observe single molecules May 23rd, 2015